Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat.
about
Consumption of green tea, but not black tea or coffee, is associated with reduced risk of cognitive decline.The efficacy of Epigallocatechin-3-gallate (green tea) in the treatment of Alzheimer's disease: an overview of pre-clinical studies and translational perspectives in clinical practice.Randomized controlled trial of the effects of consumption of 'Yabukita' or 'Benifuuki' encapsulated tea-powder on low-density lipoprotein cholesterol level and body weight.Legionella pneumophila replication in macrophages inhibited by selective immunomodulatory effects on cytokine formation by epigallocatechin gallate, a major form of tea catechinsModulation of Ca²⁺ signals by epigallocatechin-3-gallate(EGCG) in cultured rat hippocampal neuronsTea and human health: biomedical functions of tea active components and current issuesGreen tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis. [corrected].Semaphorins in axon regeneration: developmental guidance molecules gone wrong?Stuck at the bench: Potential natural neuroprotective compounds for concussion.Telomere maintenance in childhood primitive neuroectodermal brain tumors.Do polyphenols enter the brain and does it matter? Some theoretical and practical considerationsExposure to green tea extract alters the incidence of specific cyclophosphamide-induced malformationsEpigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?Neuroprotective Activity of (-)-Epigallocatechin Gallate against Lipopolysaccharide-Mediated CytotoxicityThe effect of green tea consumption on oxidative stress markers and cognitive function in patients with Alzheimer's disease: A prospective intervention study.Pharmacokinetics of green tea catechins in extract and sustained-release preparations.Cancer prevention trial of a synergistic mixture of green tea concentrate plus Capsicum (CAPSOL-T) in a random population of subjects ages 40-84.Pharmacokinetic and chemoprevention studies on tea in humans.Mechanism of synergy between epigallocatechin gallate and beta-lactams against methicillin-resistant Staphylococcus aureus.In vitro toxicity of epigallocatechin gallate in rat liver mitochondria and hepatocytes.Epigallocatechin gallate synergistically enhances the activity of carbapenems against methicillin-resistant Staphylococcus aureusInhibition of penicillinase by epigallocatechin gallate resulting in restoration of antibacterial activity of penicillin against penicillinase-producing Staphylococcus aureusTargeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits.The Antimicrobial Activity of (-)-Epigallocatehin-3-Gallate and Green Tea Extracts against Pseudomonas aeruginosa and Escherichia coli Isolated from Skin Wounds.Nutrient sensing in pancreatic islets: lessons from congenital hyperinsulinism and monogenic diabetes.Effects of Tea Catechins on Alzheimer's Disease: Recent Updates and Perspectives
P2860
Q33609878-D532EEE7-1A0E-4BB9-B46A-FEC80FC762F8Q33814399-F3977EE8-7D50-4A46-9FAC-71C77CC6D389Q33856284-CF6FA434-3612-4656-96C5-1B93538135A7Q34007954-66DB13D2-2078-4793-B525-1B910D1A7401Q34578174-1C0DE91C-A91C-4C0B-A9D0-C69E503C69BFQ35065939-26CDCC9F-529E-40B2-80BD-0FC2A64B5C02Q35135845-004E5AFD-6138-412E-BA91-C68DBE73C3CBQ35172127-675646CE-78F3-48CE-A70F-3C28A8491712Q35493114-49BC49D0-0203-4318-9E42-D785A8E0A4DAQ35800682-C6ECD038-D9B4-4E1D-9503-8CBC478682AEQ35863348-702B081A-1686-453B-8865-3661406030A3Q36041263-FDE6EE69-3E77-46E5-B18C-0032D29096FEQ36648907-1E9C55E4-C1BC-4CCF-9BF3-47F3F1B93B01Q36835232-E764C85D-74F2-48F7-9108-16D6F65C9B33Q37335685-9A9B8926-85F0-4B43-8D74-C2C9D4BF0F83Q37355604-71D85762-9F23-4DDA-BB0E-484D5C5B37A0Q37515432-B8F2B9CE-EFE4-456D-AE1A-820EFE01CC48Q37882092-0A666961-0865-47D6-929D-7E35042D24ABQ39477432-1CEE303A-345B-4E22-8446-2F47C1488C8CQ39636047-BEA84218-C7F3-4F65-8351-3855E8CA434DQ39651150-BC52C515-467E-40B7-A65F-E780D9EC9E51Q39652164-7109A998-C810-4E9B-AC48-8FF9402E4CA2Q41696401-93130ABF-B24C-48F4-9EE4-73C63352F526Q41697373-2FD2A52E-08E7-4A61-9137-56EEE5E0E587Q50088043-3E7BBBA9-E031-4338-B786-79F94E1F3E25Q58691858-A6E253CA-19FB-4E4E-9E0C-FBF3C4E65FE7
P2860
Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat.
@en
Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat.
@nl
type
label
Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat.
@en
Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat.
@nl
prefLabel
Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat.
@en
Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat.
@nl
P1476
Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat.
@en
P2093
Miyazawa T
Nakagawa K
P304
P577
1997-12-01T00:00:00Z